Sanofi is teaming with Verily on a $500M JV aimed at marrying tech with diabetes drugs
A year after the pharma giant Sanofi $SNY agreed to collaborate with Verily Life Sciences (formerly Google Life Sciences) to spawn a new tech platform for managing diabetes, the global companies are following up by establishing a new joint venture that will be tasked with accomplishing the alpine goals they’ve set out for themselves.
Based in Kendall Square — ground zero in the global biotech hub in Cambridge, MA — the new Onduo will be led by Joshua Riff, a veteran of the U.S. managed care world, where disease management has become a core focus for some of the country’s biggest insurers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
